← Back to headlines
Corvus Outlines Soquelitinib Milestones for PTCL and AD Data
Corvus Pharmaceuticals has outlined key milestones for its drug soquelitinib, including a PTCL futility analysis in Q1 2027 and Alzheimer's Disease (AD) topline data in Q3 2027.
7 Aug, 08:45 — 7 Aug, 08:45
Sources
Showing 1 of 1 sources
